ketanserin has been researched along with Cirrhoses, Experimental Liver in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of ketanserin on inflammation, liver fibrosis, and microviscosity of the plasma and mitochondrial membranes of hepatocytes was studied on young (3 months) and old (9 months) male Wistar rats with experimental liver cirrhosis." | 8.12 | Age-Related Features of Ketanserin Effects in Experimental Liver Cirrhosis. ( Afanas'ev, SA; Dygai, АМ; Ermakova, NN; Kogai, LV; Pakhomova, AV; Pan, ES; Pershina, ОV; Putrova, ОD; Rebrova, ТY; Sandrikina, LА; Skurikhin, ЕG; Zhukova, МА, 2022) |
| "The effect of ketanserin on inflammation, liver fibrosis, and microviscosity of the plasma and mitochondrial membranes of hepatocytes was studied on young (3 months) and old (9 months) male Wistar rats with experimental liver cirrhosis." | 4.12 | Age-Related Features of Ketanserin Effects in Experimental Liver Cirrhosis. ( Afanas'ev, SA; Dygai, АМ; Ermakova, NN; Kogai, LV; Pakhomova, AV; Pan, ES; Pershina, ОV; Putrova, ОD; Rebrova, ТY; Sandrikina, LА; Skurikhin, ЕG; Zhukova, МА, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, ES | 1 |
| Pakhomova, AV | 1 |
| Ermakova, NN | 1 |
| Afanas'ev, SA | 1 |
| Rebrova, ТY | 1 |
| Zhukova, МА | 1 |
| Sandrikina, LА | 1 |
| Putrova, ОD | 1 |
| Kogai, LV | 1 |
| Pershina, ОV | 1 |
| Dygai, АМ | 1 |
| Skurikhin, ЕG | 1 |
| Kim, DC | 1 |
| Jun, DW | 1 |
| Kwon, YI | 1 |
| Lee, KN | 1 |
| Lee, HL | 1 |
| Lee, OY | 1 |
| Yoon, BC | 1 |
| Choi, HS | 1 |
| Kim, EK | 1 |
| Ghia, M | 1 |
| Mereto, E | 1 |
| Mattioli, F | 1 |
| Dagnino, F | 1 |
| Testa, R | 1 |
3 other studies available for ketanserin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Age-Related Features of Ketanserin Effects in Experimental Liver Cirrhosis.
Topics: Animals; Hepatocytes; Inflammation; Ketanserin; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimenta | 2022 |
5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis.
Topics: Actins; Animals; Apoptosis; Cell Line; Cell Survival; Collagen Type I; Dose-Response Relationship, D | 2013 |
Splanchnic haemodynamic effects of ketanserin in anaesthetized cirrhotic rats.
Topics: Animals; Atenolol; Bile Acids and Salts; Blood Pressure; Carbon Tetrachloride; Chenodeoxycholic Acid | 1992 |